Clinical trial
Vasopressin in Traumatic Hemorrhagic Shock Study
NCT00379522 · Volker Wenzel, Other · Completed
Key facts
| NCT number | NCT00379522 |
|---|---|
| Title | Vasopressin in Traumatic Hemorrhagic Shock Study |
| Official title | A Multicenter, Randomized, Controlled Trial Assessing Arginine Vasopressin Versus Saline Placebo in Refractory Traumatic Hemorrhagic Shock Patients (VITRIS-study) |
| Lead sponsor | Volker Wenzel, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Shock, Hypovolemia, Hemorrhagic Shock |
| Intervention type | Drug |
| Interventions | Vasopressin, Saline placebo |
| Enrollment | 64 |
| Start date | Jul 1, 2010 |
| Primary completion | Oct 1, 2014 |
| Completion | Oct 1, 2014 |
| First posted | Sep 22, 2006 |
| Last update posted | Nov 5, 2014 |
| Countries | Austria, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: